RNS Number : 1188N
Intelligent Ultrasound Group PLC
18 May 2020

Intelligent Ultrasound Group plc

("Intelligent Ultrasound" or the "Company")

Notice of Annual General Meeting and publication of 2019 Annual Report

Intelligent Ultrasound Group plc (AIM: MED), the artificial intelligence software and simulation company, announces that the Company's Annual General Meeting ("AGM") will be held� at the Company's registered office address, Cardiff Medicentre, Heath Park, Cardiff, CF14 4UJ on 18 June 2020 at 11:00 a.m. The Notice of AGM will be available to download from the Company's website at www.intelligentultrasoundgroup.com/reports-and-presentations/.

In accordance with current Government regulations in relation to COVID-19, shareholders are encouraged to submit their Form of Proxy in advance of the AGM, as to attend the AGM in person would, as at the date of this announcement, be inconsistent with the relevant regulations. Shareholders who attempt to attend the AGM in person in breach of the stay at home measures will not be admitted.

Further to its preliminary results announcement issued on �26 March 2020, the 2019 Annual Report and Accounts (the "Annual Report") for the financial year ended 31 December 2019 has been published on the Company's website,�www.intelligentultrasoundgroup.com/reports-and-presentations/. Copies of the 2019 Annual Report and the Notice of AGM have been posted to shareholders that have requested a printed copy.

Enquiries:

Intelligent Ultrasound Group plc

www.intelligentultrasound.com

Stuart Gall, CEO
Helen Jones, CFO

Tel: +44 (0)29 2075 6534



Cenkos Securities plc

Tel:� +44 (0)20 7397 8900

Giles Balleny/Cameron MacRitchie (Nominated Adviser)


Michael Johnson/Julian Morse (Corporate Broking)




Walbrook PR

Tel: +44 (0)20 7933 8780

or�[email protected]

Anna Dunphy/Paul McManus

Mob: +44 (0)7876 741 001/Mob: +44 (0)7980 541 893


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
MSCZZGMKNKKGGZM